Physician
Associated Pathologists, P.A.
Associated Pathologists, P.A. was paid $5.58M by Medicaid between Jan 2018 and Dec 2024, across 242 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 18% of everything it billed.
33Billing provider infoASSOCIATED PATHOLOGISTS, P.A.
TAMPA, FL 33607
TAMPA, FL 33607
33aNPI1194740787assigned 07/13/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$5.58M
24GClaims2,472,178
24DCodes billed242
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#5 of 207
Median peer was paid$39K
This provider vs. median142×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 77,674 | $73K | |
| 2019 | 414,418 | $827K | |
| 2020 | 395,956 | $1.49M | |
| 2021 | 459,290 | $916K | |
| 2022 | 419,345 | $792K | |
| 2023 | 434,537 | $1.05M | |
| 2024incomplete | 270,958 | $424K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18% | 15,096 | 13,160 | $986K |
| 80053 | Comprehensive metabolic panel | 15% | 190,962 | 141,837 | $854K |
| 80048 | Basic metabolic panel (calcium, ionized) | 9.1% | 187,355 | 87,867 | $510K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.4% | 15,704 | 14,653 | $355K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.2% | 292,343 | 198,065 | $292K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.0% | 31,960 | 30,787 | $168K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 4,708 | 4,200 | $155K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.6% | 11,321 | 10,144 | $148K |
| 82948 | 2.6% | 266,317 | 65,240 | $146K | |
| 81003 | 1.6% | 133,353 | 117,645 | $91K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.5% | 4,401 | 4,144 | $85K |
| 87641 | 1.5% | 15,718 | 14,040 | $82K |
230 more codes
| 84484 | 1.1% | 63,801 | $62K | |
| 88307 | 1.1% | 1,208 | $60K | |
| 85027 | <1% | 87,658 | $55K | |
| 87480 | <1% | 9,147 | $53K | |
| 83735 | <1% | 79,873 | $53K | |
| 87040 | <1% | 34,280 | $49K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,655 | $49K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 19,899 | $48K |
| 0100U | <1% | 2,677 | $47K | |
| 88312 | <1% | 3,797 | $37K | |
| 81001 | <1% | 25,477 | $35K | |
| 82805 | <1% | 7,381 | $34K | |
| 84703 | <1% | 35,924 | $32K | |
| 86900 | <1% | 54,612 | $31K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16,004 | $29K |
| 87481 | <1% | 3,271 | $28K | |
| 83690 | <1% | 49,010 | $27K | |
| 83020 | <1% | 2,917 | $26K | |
| 86850 | <1% | 33,537 | $25K | |
| 87486 | <1% | 1,516 | $24K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 29,652 | $24K |
| 88304 | <1% | 1,857 | $23K | |
| 83605 | <1% | 25,024 | $23K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,316 | $22K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,044 | $22K |
| 82330 | <1% | 10,779 | $21K | |
| 80074 | <1% | 3,604 | $21K | |
| 84702 | <1% | 16,428 | $21K | |
| 88342 | <1% | 2,037 | $20K | |
| 85610 | <1% | 52,298 | $20K | |
| 86140 | <1% | 34,609 | $19K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,732 | $19K |
| 80050 | General health panel | <1% | 1,158 | $18K |
| 80202 | <1% | 6,938 | $18K | |
| 87506 | <1% | 1,709 | $17K | |
| 87070 | <1% | 7,542 | $16K | |
| 87631 | <1% | 2,330 | $16K | |
| 82247 | <1% | 14,161 | $16K | |
| 80076 | <1% | 17,235 | $16K | |
| 85730 | <1% | 27,923 | $15K | |
| 87077 | <1% | 9,892 | $15K | |
| 87015 | <1% | 3,095 | $15K | |
| 80061 | Lipid panel | <1% | 9,322 | $14K |
| 84100 | <1% | 31,986 | $13K | |
| 82728 | <1% | 8,549 | $13K | |
| 86901 | <1% | 51,696 | $13K | |
| 87529 | <1% | 1,479 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,697 | $12K |
| 86762 | <1% | 5,882 | $11K | |
| 87340 | <1% | 10,614 | $11K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 318 | $11K |
| 87660 | <1% | 9,584 | $9K | |
| 86665 | <1% | 1,066 | $9K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 679 | $9K |
| 82550 | <1% | 11,756 | $9K | |
| 86003 | <1% | 740 | $9K | |
| 85014 | <1% | 19,964 | $8K | |
| 85380 | <1% | 11,536 | $8K | |
| 87640 | <1% | 2,284 | $8K | |
| 81025 | <1% | 6,870 | $8K | |
| 82607 | <1% | 3,351 | $8K | |
| 87653 | <1% | 1,420 | $8K | |
| 87149 | <1% | 3,321 | $7K | |
| 85576 | <1% | 1,845 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 690 | $7K |
| 87510 | <1% | 9,162 | $7K | |
| 88341 | <1% | 219 | $7K | |
| 82803 | <1% | 2,185 | $7K | |
| 86880 | <1% | 9,342 | $7K | |
| 85044 | <1% | 8,756 | $7K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 493 | $7K |
| 80069 | <1% | 3,822 | $6K | |
| 82784 | <1% | 1,724 | $6K | |
| 82785 | <1% | 928 | $6K | |
| 82746 | <1% | 2,716 | $5K | |
| 85384 | <1% | 5,580 | $5K | |
| 86592 | <1% | 5,475 | $5K | |
| 83615 | <1% | 8,595 | $5K | |
| 88377 | <1% | 245 | $5K | |
| 85520 | <1% | 3,613 | $5K | |
| 82140 | <1% | 3,631 | $5K | |
| 87899 | <1% | 1,626 | $5K | |
| 83540 | <1% | 5,534 | $5K | |
| 85652 | <1% | 10,930 | $5K | |
| 86905 | <1% | 1,056 | $4K | |
| 80164 | <1% | 2,159 | $4K | |
| 87186 | <1% | 10,006 | $4K | |
| 82248 | <1% | 8,184 | $4K | |
| 87205 | <1% | 10,258 | $4K | |
| 84132 | <1% | 8,789 | $4K | |
| 84439 | <1% | 3,669 | $4K | |
| 85018 | <1% | 19,923 | $4K | |
| 86038 | <1% | 1,699 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,758 | $3K |
| 87449 | <1% | 1,424 | $3K | |
| 83550 | <1% | 4,149 | $3K | |
| 84112 | <1% | 638 | $3K | |
| 82951 | <1% | 1,896 | $3K | |
| 83880 | <1% | 5,551 | $3K | |
| 87081 | <1% | 2,857 | $3K | |
| 84295 | <1% | 4,947 | $3K | |
| 0353U | <1% | 2,319 | $3K | |
| 0240U | <1% | 561 | $3K | |
| 86376 | <1% | 909 | $3K | |
| 86480 | <1% | 327 | $3K | |
| 87075 | <1% | 3,573 | $3K | |
| 83520 | <1% | 873 | $3K | |
| 82533 | <1% | 1,007 | $3K | |
| 88189 | <1% | 41 | $3K | |
| 85060 | <1% | 159 | $2K | |
| 82945 | <1% | 2,205 | $2K | |
| 82570 | <1% | 4,340 | $2K | |
| 82270 | <1% | 1,185 | $2K | |
| 82375 | <1% | 2,861 | $2K | |
| 83970 | <1% | 590 | $2K | |
| 82962 | <1% | 2,820 | $2K | |
| 88108 | <1% | 155 | $2K | |
| 84478 | <1% | 3,117 | $2K | |
| 85347 | <1% | 2,206 | $2K | |
| 85390 | <1% | 197 | $2K | |
| 85379 | <1% | 3,059 | $2K | |
| 84481 | <1% | 1,048 | $2K | |
| 84145 | <1% | 9,376 | $2K | |
| 84155 | <1% | 5,698 | $2K | |
| 86356 | <1% | 922 | $2K | |
| 87425 | <1% | 727 | $2K | |
| 84550 | <1% | 3,243 | $1K | |
| 86663 | <1% | 946 | $1K | |
| 86664 | <1% | 980 | $1K | |
| 0352U | <1% | 703 | $1K | |
| 83021 | <1% | 837 | $1K | |
| 82150 | <1% | 880 | $1K | |
| 87807 | <1% | 317 | $1K | |
| 86780 | <1% | 1,077 | $1K | |
| 86317 | <1% | 795 | $1K | |
| 87536 | <1% | 119 | $1K | |
| 83050 | <1% | 2,722 | $1K | |
| 80177 | <1% | 590 | $1K | |
| 86308 | <1% | 1,026 | $969.05 | |
| 87521 | Neg quan hep c or qual rna | <1% | 195 | $908.64 |
| 87045 | <1% | 1,586 | $859.66 | |
| 86923 | <1% | 8,311 | $798.67 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,841 | $766.83 |
| 87206 | <1% | 1,659 | $750.18 | |
| 87116 | <1% | 1,391 | $730.15 | |
| 82010 | <1% | 1,502 | $727.18 | |
| 87496 | <1% | 116 | $695.09 | |
| 84436 | <1% | 576 | $686.28 | |
| 87581 | <1% | 1,511 | $674.28 | |
| 87102 | <1% | 1,358 | $650.06 | |
| 82465 | <1% | 386 | $585.97 | |
| 83930 | <1% | 650 | $578.73 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 29 | $540.84 |
| 86803 | <1% | 193 | $539.28 | |
| 83935 | <1% | 556 | $526.44 | |
| 86922 | <1% | 28 | $508.24 | |
| 82731 | <1% | 97 | $491.41 | |
| 87498 | <1% | 214 | $482.55 | |
| 84300 | <1% | 1,371 | $475.35 | |
| 88313 | <1% | 47 | $380.03 | |
| 86360 | <1% | 927 | $360.14 | |
| 84480 | <1% | 330 | $345.77 | |
| 85660 | <1% | 736 | $332.29 | |
| 87046 | <1% | 1,590 | $331.22 | |
| 82139 | <1% | 121 | $315.03 | |
| 80178 | <1% | 265 | $305.70 | |
| 89050 | <1% | 698 | $298.50 | |
| 87328 | <1% | 178 | $287.09 | |
| 87252 | <1% | 391 | $284.07 | |
| 87541 | <1% | 73 | $283.34 | |
| 88300 | <1% | 69 | $273.38 | |
| 82977 | <1% | 291 | $253.17 | |
| 86870 | <1% | 343 | $238.36 | |
| 86645 | <1% | 140 | $235.60 | |
| 86706 | <1% | 132 | $231.18 | |
| 87329 | <1% | 179 | $221.49 | |
| 85045 | <1% | 211 | $199.53 | |
| 86255 | <1% | 39 | $191.65 | |
| 82378 | <1% | 72 | $181.48 | |
| 87106 | <1% | 330 | $179.36 | |
| 87493 | <1% | 1,089 | $157.92 | |
| 86709 | <1% | 188 | $157.85 | |
| 84165 | <1% | 184 | $152.26 | |
| 88142 | <1% | 57 | $148.52 | |
| 84134 | <1% | 81 | $145.39 | |
| 86769 | <1% | 39 | $139.87 | |
| 87430 | <1% | 157 | $132.48 | |
| 83701 | <1% | 230 | $127.62 | |
| 85460 | <1% | 149 | $122.59 | |
| 86147 | <1% | 15 | $122.34 | |
| 86860 | <1% | 104 | $98.28 | |
| 86704 | <1% | 58 | $87.98 | |
| 80500 | <1% | 29 | $84.85 | |
| 88311 | <1% | 12 | $76.72 | |
| 86644 | <1% | 49 | $70.65 | |
| 89051 | <1% | 184 | $61.15 | |
| 85049 | <1% | 98 | $59.46 | |
| 86431 | <1% | 122 | $57.37 | |
| 86334 | <1% | 109 | $56.59 | |
| 82952 | <1% | 79 | $52.97 | |
| 86039 | <1% | 78 | $51.96 | |
| 83883 | <1% | 14 | $51.21 | |
| 87593 | <1% | 14 | $50.28 | |
| 82274 | <1% | 14 | $49.71 | |
| 87177 | <1% | 43 | $45.55 | |
| 85705 | <1% | 71 | $41.51 | |
| 86225 | <1% | 45 | $39.72 | |
| 86593 | <1% | 91 | $38.94 | |
| 82947 | <1% | 52 | $38.83 | |
| 83516 | <1% | 51 | $36.22 | |
| 82436 | <1% | 143 | $34.81 | |
| 87400 | <1% | 156 | $30.89 | |
| 82365 | <1% | 12 | $21.23 | |
| 87181 | <1% | 426 | $19.52 | |
| 87281 | <1% | 59 | $16.74 | |
| 84133 | <1% | 54 | $15.12 | |
| 86696 | <1% | 16 | $15.00 | |
| 87209 | <1% | 43 | $13.21 | |
| 86787 | <1% | 14 | $12.15 | |
| 82310 | <1% | 27 | $11.42 | |
| 86695 | <1% | 15 | $8.08 | |
| 84075 | <1% | 36 | $6.39 | |
| 82042 | <1% | 27 | $4.66 | |
| 82043 | <1% | 12 | $1.08 | |
| 85651 | <1% | 59 | $0.98 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 1,425 | $0.00 |
| 87338 | 0% | 13 | $0.00 | |
| 82077 | 0% | 363 | $0.00 | |
| 84479 | 0% | 13 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEDGINGTON, LAUREN (ADMINISTRATOR)